Almased Multi-Center Diabetes Intervention Trial (AMDIT)
Evaluation of Almased on Glycemic Control and Metabolic Effects in Patients With Type 2 Diabetes
Sponsor: London Metropolitan University
A NA clinical study on Obesity and Type 2 Diabetes, this trial is completed. The trial is conducted by London Metropolitan University and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Aug 2018 — Feb 2020 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Completed NA
-
Mar 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Mar 2017 [monthly]
Completed NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Metropolitan University
- University of Campinas, Brazil
- University of Freiburg
- University of Mysore
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .